ARX 3.70% 65.0¢ aroa biosurgery limited

Ann: New Study Shows Myriad Efficacy in Exposed Vital Structures, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,089 Posts.
    lightbulb Created with Sketch. 460
    Arx done a staff share issue of 8mill in shares i believe.
    I would imagine it is the staff that are doing the selling as the new year holiday period is upon us.

    Arx mc - 200-300mill , PNV mc - ~1.5bill

    ARX is on par with PNV in revenue,

    Debt levels are about the same - ARX a bit lower

    ARX has more cash on hand due to the raise

    ARX has more fda approved products currently but with less market depth - ARX has been in the US market only where as PNV is pretty mich worldwide with their 1 or 2 products. Note that Arx revenue is the same tho....

    ARX has recently issued anns noting they are now approved for India and Europe -

    This sell off is a great short opportunity as per Erics motives or a great entry point for longs.
    This will most likely catch up to PNV by the next half yearly

 
watchlist Created with Sketch. Add ARX (ASX) to my watchlist
(20min delay)
Last
65.0¢
Change
-0.025(3.70%)
Mkt cap ! $224.1M
Open High Low Value Volume
67.5¢ 68.0¢ 65.0¢ $149.2K 226.5K

Buyers (Bids)

No. Vol. Price($)
7 39251 65.0¢
 

Sellers (Offers)

Price($) Vol. No.
68.0¢ 16800 2
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
ARX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.